Arbutus Biopharma (ABUS) Acquisitions (2015)

Arbutus Biopharma's (ABUS) quarterly Acquisitions came in at $324000.0 in Q1 2015.

Arbutus Biopharma (ABUS) Acquisitions (2015) Analysis & Trends

Arbutus Biopharma has disclosed Acquisitions across 1 years of filings, most recently posting $324000.0 for Q1 2015.

Acquisitions for Q1 2015 came in at $324000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $324000.0 (changed N/A YoY), and the FY2015 annual result was $324000.0, changed N/A from the prior year.
Acquisitions came in at $324000.0 for Q1 2015 at Arbutus Biopharma.
In the past five years, Acquisitions ranged from a high of $324000.0 in Q1 2015 to a low of $324000.0 in Q1 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Arbutus Biopharma	882.62 Mn	882.62 Mn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2015	324,000.00